[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Streptococcus Pneumoniae Vaccine Market - Global Outlook and Forecast 2022-2028

March 2022 | 125 pages | ID: S0E37F6DCC4FEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Streptococcus Pneumoniae Vaccine in global, including the following market information:

Global Streptococcus Pneumoniae Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Streptococcus Pneumoniae Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Streptococcus Pneumoniae Vaccine companies in 2021 (%)

The global Streptococcus Pneumoniae Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

7 -Valent Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Streptococcus Pneumoniae Vaccine include Pfizer, Sanofi, GSK, Merck, Eli Lilly, AstraZeneca, Abera, S K Chemicals and Beijing Minhai Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Streptococcus Pneumoniae Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Streptococcus Pneumoniae Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Streptococcus Pneumoniae Vaccine Market Segment Percentages, by Type, 2021 (%)
  • 7 -Valent
  • 10 -Valent
  • 13 -Valent
  • 15 -Valent
  • 23 -Valent
  • Other
Global Streptococcus Pneumoniae Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Streptococcus Pneumoniae Vaccine Market Segment Percentages, by Application, 2021 (%)
  • Children under 2 Years of Age
  • Adults over 65 Years of Age
  • Addicted Smokers Between the Ages of 19 and 64
  • Other
Global Streptococcus Pneumoniae Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Streptococcus Pneumoniae Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Streptococcus Pneumoniae Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Streptococcus Pneumoniae Vaccine revenues share in global market, 2021 (%)

Key companies Streptococcus Pneumoniae Vaccine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Streptococcus Pneumoniae Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Pfizer
  • Sanofi
  • GSK
  • Merck
  • Eli Lilly
  • AstraZeneca
  • Abera
  • S K Chemicals
  • Beijing Minhai Biotechnology
  • Baxter
  • Biken
  • Celgene Corporation
  • Panacea Biotec
  • Serum Institute of India
  • Genentech
  • Genocea Biosciences
  • ImmunoBiology
  • Lupin
  • Nuron Biotech
  • Biogen
  • Valneva Austria
  • Sinovac
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Streptococcus Pneumoniae Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Streptococcus Pneumoniae Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL STREPTOCOCCUS PNEUMONIAE VACCINE OVERALL MARKET SIZE

2.1 Global Streptococcus Pneumoniae Vaccine Market Size: 2021 VS 2028
2.2 Global Streptococcus Pneumoniae Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Streptococcus Pneumoniae Vaccine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Streptococcus Pneumoniae Vaccine Players in Global Market
3.2 Top Global Streptococcus Pneumoniae Vaccine Companies Ranked by Revenue
3.3 Global Streptococcus Pneumoniae Vaccine Revenue by Companies
3.4 Global Streptococcus Pneumoniae Vaccine Sales by Companies
3.5 Global Streptococcus Pneumoniae Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Streptococcus Pneumoniae Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Streptococcus Pneumoniae Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Streptococcus Pneumoniae Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Streptococcus Pneumoniae Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Streptococcus Pneumoniae Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Streptococcus Pneumoniae Vaccine Market Size Markets, 2021 & 2028
  4.1.2 7 -Valent
  4.1.3 10 -Valent
  4.1.4 13 -Valent
  4.1.5 15 -Valent
  4.1.6 23 -Valent
  4.1.7 Other
4.2 By Type - Global Streptococcus Pneumoniae Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Streptococcus Pneumoniae Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Streptococcus Pneumoniae Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Streptococcus Pneumoniae Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Streptococcus Pneumoniae Vaccine Sales & Forecasts
  4.3.1 By Type - Global Streptococcus Pneumoniae Vaccine Sales, 2017-2022
  4.3.2 By Type - Global Streptococcus Pneumoniae Vaccine Sales, 2023-2028
  4.3.3 By Type - Global Streptococcus Pneumoniae Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Streptococcus Pneumoniae Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Streptococcus Pneumoniae Vaccine Market Size, 2021 & 2028
  5.1.2 Children under 2 Years of Age
  5.1.3 Adults over 65 Years of Age
  5.1.4 Addicted Smokers Between the Ages of 19 and
  5.1.5 Other
5.2 By Application - Global Streptococcus Pneumoniae Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Streptococcus Pneumoniae Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Streptococcus Pneumoniae Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Streptococcus Pneumoniae Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Streptococcus Pneumoniae Vaccine Sales & Forecasts
  5.3.1 By Application - Global Streptococcus Pneumoniae Vaccine Sales, 2017-2022
  5.3.2 By Application - Global Streptococcus Pneumoniae Vaccine Sales, 2023-2028
  5.3.3 By Application - Global Streptococcus Pneumoniae Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Streptococcus Pneumoniae Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Streptococcus Pneumoniae Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Streptococcus Pneumoniae Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Streptococcus Pneumoniae Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Streptococcus Pneumoniae Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Streptococcus Pneumoniae Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Streptococcus Pneumoniae Vaccine Sales & Forecasts
  6.3.1 By Region - Global Streptococcus Pneumoniae Vaccine Sales, 2017-2022
  6.3.2 By Region - Global Streptococcus Pneumoniae Vaccine Sales, 2023-2028
  6.3.3 By Region - Global Streptococcus Pneumoniae Vaccine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Streptococcus Pneumoniae Vaccine Revenue, 2017-2028
  6.4.2 By Country - North America Streptococcus Pneumoniae Vaccine Sales, 2017-2028
  6.4.3 US Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.4.4 Canada Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.4.5 Mexico Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Streptococcus Pneumoniae Vaccine Revenue, 2017-2028
  6.5.2 By Country - Europe Streptococcus Pneumoniae Vaccine Sales, 2017-2028
  6.5.3 Germany Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.5.4 France Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.5.5 U.K. Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.5.6 Italy Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.5.7 Russia Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.5.8 Nordic Countries Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.5.9 Benelux Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Streptococcus Pneumoniae Vaccine Revenue, 2017-2028
  6.6.2 By Region - Asia Streptococcus Pneumoniae Vaccine Sales, 2017-2028
  6.6.3 China Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.6.4 Japan Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.6.5 South Korea Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.6.6 Southeast Asia Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.6.7 India Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Streptococcus Pneumoniae Vaccine Revenue, 2017-2028
  6.7.2 By Country - South America Streptococcus Pneumoniae Vaccine Sales, 2017-2028
  6.7.3 Brazil Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.7.4 Argentina Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Streptococcus Pneumoniae Vaccine Sales, 2017-2028
  6.8.3 Turkey Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.8.4 Israel Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.8.5 Saudi Arabia Streptococcus Pneumoniae Vaccine Market Size, 2017-2028
  6.8.6 UAE Streptococcus Pneumoniae Vaccine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.1.4 Pfizer Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.1.5 Pfizer Key News
7.2 Sanofi
  7.2.1 Sanofi Corporate Summary
  7.2.2 Sanofi Business Overview
  7.2.3 Sanofi Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.2.4 Sanofi Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.2.5 Sanofi Key News
7.3 GSK
  7.3.1 GSK Corporate Summary
  7.3.2 GSK Business Overview
  7.3.3 GSK Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.3.4 GSK Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.3.5 GSK Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.4.4 Merck Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.4.5 Merck Key News
7.5 Eli Lilly
  7.5.1 Eli Lilly Corporate Summary
  7.5.2 Eli Lilly Business Overview
  7.5.3 Eli Lilly Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.5.4 Eli Lilly Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.5.5 Eli Lilly Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.6.4 AstraZeneca Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.6.5 AstraZeneca Key News
7.7 Abera
  7.7.1 Abera Corporate Summary
  7.7.2 Abera Business Overview
  7.7.3 Abera Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.7.4 Abera Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.7.5 Abera Key News
7.8 S K Chemicals
  7.8.1 S K Chemicals Corporate Summary
  7.8.2 S K Chemicals Business Overview
  7.8.3 S K Chemicals Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.8.4 S K Chemicals Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.8.5 S K Chemicals Key News
7.9 Beijing Minhai Biotechnology
  7.9.1 Beijing Minhai Biotechnology Corporate Summary
  7.9.2 Beijing Minhai Biotechnology Business Overview
  7.9.3 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.9.4 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.9.5 Beijing Minhai Biotechnology Key News
7.10 Baxter
  7.10.1 Baxter Corporate Summary
  7.10.2 Baxter Business Overview
  7.10.3 Baxter Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.10.4 Baxter Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.10.5 Baxter Key News
7.11 Biken
  7.11.1 Biken Corporate Summary
  7.11.2 Biken Streptococcus Pneumoniae Vaccine Business Overview
  7.11.3 Biken Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.11.4 Biken Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.11.5 Biken Key News
7.12 Celgene Corporation
  7.12.1 Celgene Corporation Corporate Summary
  7.12.2 Celgene Corporation Streptococcus Pneumoniae Vaccine Business Overview
  7.12.3 Celgene Corporation Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.12.4 Celgene Corporation Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.12.5 Celgene Corporation Key News
7.13 Panacea Biotec
  7.13.1 Panacea Biotec Corporate Summary
  7.13.2 Panacea Biotec Streptococcus Pneumoniae Vaccine Business Overview
  7.13.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.13.4 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.13.5 Panacea Biotec Key News
7.14 Serum Institute of India
  7.14.1 Serum Institute of India Corporate Summary
  7.14.2 Serum Institute of India Business Overview
  7.14.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.14.4 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.14.5 Serum Institute of India Key News
7.15 Genentech
  7.15.1 Genentech Corporate Summary
  7.15.2 Genentech Business Overview
  7.15.3 Genentech Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.15.4 Genentech Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.15.5 Genentech Key News
7.16 Genocea Biosciences
  7.16.1 Genocea Biosciences Corporate Summary
  7.16.2 Genocea Biosciences Business Overview
  7.16.3 Genocea Biosciences Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.16.4 Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.16.5 Genocea Biosciences Key News
7.17 ImmunoBiology
  7.17.1 ImmunoBiology Corporate Summary
  7.17.2 ImmunoBiology Business Overview
  7.17.3 ImmunoBiology Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.17.4 ImmunoBiology Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.17.5 ImmunoBiology Key News
7.18 Lupin
  7.18.1 Lupin Corporate Summary
  7.18.2 Lupin Business Overview
  7.18.3 Lupin Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.18.4 Lupin Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.18.5 Lupin Key News
7.19 Nuron Biotech
  7.19.1 Nuron Biotech Corporate Summary
  7.19.2 Nuron Biotech Business Overview
  7.19.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.19.4 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.19.5 Nuron Biotech Key News
7.20 Biogen
  7.20.1 Biogen Corporate Summary
  7.20.2 Biogen Business Overview
  7.20.3 Biogen Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.20.4 Biogen Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.20.5 Biogen Key News
7.21 Valneva Austria
  7.21.1 Valneva Austria Corporate Summary
  7.21.2 Valneva Austria Business Overview
  7.21.3 Valneva Austria Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.21.4 Valneva Austria Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.21.5 Valneva Austria Key News
7.22 Sinovac
  7.22.1 Sinovac Corporate Summary
  7.22.2 Sinovac Business Overview
  7.22.3 Sinovac Streptococcus Pneumoniae Vaccine Major Product Offerings
  7.22.4 Sinovac Streptococcus Pneumoniae Vaccine Sales and Revenue in Global (2017-2022)
  7.22.5 Sinovac Key News

8 GLOBAL STREPTOCOCCUS PNEUMONIAE VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Streptococcus Pneumoniae Vaccine Production Capacity, 2017-2028
8.2 Streptococcus Pneumoniae Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Streptococcus Pneumoniae Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 STREPTOCOCCUS PNEUMONIAE VACCINE SUPPLY CHAIN ANALYSIS

10.1 Streptococcus Pneumoniae Vaccine Industry Value Chain
10.2 Streptococcus Pneumoniae Vaccine Upstream Market
10.3 Streptococcus Pneumoniae Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Streptococcus Pneumoniae Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Streptococcus Pneumoniae Vaccine in Global Market
Table 2. Top Streptococcus Pneumoniae Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Streptococcus Pneumoniae Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Streptococcus Pneumoniae Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Streptococcus Pneumoniae Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Streptococcus Pneumoniae Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Streptococcus Pneumoniae Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Streptococcus Pneumoniae Vaccine Product Type
Table 9. List of Global Tier 1 Streptococcus Pneumoniae Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Streptococcus Pneumoniae Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Streptococcus Pneumoniae Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Streptococcus Pneumoniae Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Streptococcus Pneumoniae Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Streptococcus Pneumoniae Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Streptococcus Pneumoniae Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Streptococcus Pneumoniae Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Streptococcus Pneumoniae Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Streptococcus Pneumoniae Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Streptococcus Pneumoniae Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Streptococcus Pneumoniae Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Streptococcus Pneumoniae Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Streptococcus Pneumoniae Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Streptococcus Pneumoniae Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Streptococcus Pneumoniae Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Streptococcus Pneumoniae Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Streptococcus Pneumoniae Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Streptococcus Pneumoniae Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Streptococcus Pneumoniae Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Streptococcus Pneumoniae Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Streptococcus Pneumoniae Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Streptococcus Pneumoniae Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Streptococcus Pneumoniae Vaccine Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Streptococcus Pneumoniae Vaccine Product Offerings
Table 48. Pfizer Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Streptococcus Pneumoniae Vaccine Product Offerings
Table 51. Sanofi Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. GSK Corporate Summary
Table 53. GSK Streptococcus Pneumoniae Vaccine Product Offerings
Table 54. GSK Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Merck Corporate Summary
Table 56. Merck Streptococcus Pneumoniae Vaccine Product Offerings
Table 57. Merck Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Eli Lilly Corporate Summary
Table 59. Eli Lilly Streptococcus Pneumoniae Vaccine Product Offerings
Table 60. Eli Lilly Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. AstraZeneca Corporate Summary
Table 62. AstraZeneca Streptococcus Pneumoniae Vaccine Product Offerings
Table 63. AstraZeneca Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Abera Corporate Summary
Table 65. Abera Streptococcus Pneumoniae Vaccine Product Offerings
Table 66. Abera Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. S K Chemicals Corporate Summary
Table 68. S K Chemicals Streptococcus Pneumoniae Vaccine Product Offerings
Table 69. S K Chemicals Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Beijing Minhai Biotechnology Corporate Summary
Table 71. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Offerings
Table 72. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Baxter Corporate Summary
Table 74. Baxter Streptococcus Pneumoniae Vaccine Product Offerings
Table 75. Baxter Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Biken Corporate Summary
Table 77. Biken Streptococcus Pneumoniae Vaccine Product Offerings
Table 78. Biken Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Celgene Corporation Corporate Summary
Table 80. Celgene Corporation Streptococcus Pneumoniae Vaccine Product Offerings
Table 81. Celgene Corporation Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Panacea Biotec Corporate Summary
Table 83. Panacea Biotec Streptococcus Pneumoniae Vaccine Product Offerings
Table 84. Panacea Biotec Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Serum Institute of India Corporate Summary
Table 86. Serum Institute of India Streptococcus Pneumoniae Vaccine Product Offerings
Table 87. Serum Institute of India Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Genentech Corporate Summary
Table 89. Genentech Streptococcus Pneumoniae Vaccine Product Offerings
Table 90. Genentech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Genocea Biosciences Corporate Summary
Table 92. Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Offerings
Table 93. Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. ImmunoBiology Corporate Summary
Table 95. ImmunoBiology Streptococcus Pneumoniae Vaccine Product Offerings
Table 96. ImmunoBiology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Lupin Corporate Summary
Table 98. Lupin Streptococcus Pneumoniae Vaccine Product Offerings
Table 99. Lupin Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Nuron Biotech Corporate Summary
Table 101. Nuron Biotech Streptococcus Pneumoniae Vaccine Product Offerings
Table 102. Nuron Biotech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Biogen Corporate Summary
Table 104. Biogen Streptococcus Pneumoniae Vaccine Product Offerings
Table 105. Biogen Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Valneva Austria Corporate Summary
Table 107. Valneva Austria Streptococcus Pneumoniae Vaccine Product Offerings
Table 108. Valneva Austria Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 109. Sinovac Corporate Summary
Table 110. Sinovac Streptococcus Pneumoniae Vaccine Product Offerings
Table 111. Sinovac Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 112. Streptococcus Pneumoniae Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 113. Global Streptococcus Pneumoniae Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 114. Global Streptococcus Pneumoniae Vaccine Production by Region, 2017-2022 (K Units)
Table 115. Global Streptococcus Pneumoniae Vaccine Production by Region, 2023-2028 (K Units)
Table 116. Streptococcus Pneumoniae Vaccine Market Opportunities & Trends in Global Market
Table 117. Streptococcus Pneumoniae Vaccine Market Drivers in Global Market
Table 118. Streptococcus Pneumoniae Vaccine Market Restraints in Global Market
Table 119. Streptococcus Pneumoniae Vaccine Raw Materials
Table 120. Streptococcus Pneumoniae Vaccine Raw Materials Suppliers in Global Market
Table 121. Typical Streptococcus Pneumoniae Vaccine Downstream
Table 122. Streptococcus Pneumoniae Vaccine Downstream Clients in Global Market
Table 123. Streptococcus Pneumoniae Vaccine Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Streptococcus Pneumoniae Vaccine Segment by Type
Figure 2. Streptococcus Pneumoniae Vaccine Segment by Application
Figure 3. Global Streptococcus Pneumoniae Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Streptococcus Pneumoniae Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Streptococcus Pneumoniae Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Streptococcus Pneumoniae Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Streptococcus Pneumoniae Vaccine Revenue in 2021
Figure 9. By Type - Global Streptococcus Pneumoniae Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Streptococcus Pneumoniae Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Streptococcus Pneumoniae Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Streptococcus Pneumoniae Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Streptococcus Pneumoniae Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Streptococcus Pneumoniae Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Streptococcus Pneumoniae Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Streptococcus Pneumoniae Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Streptococcus Pneumoniae Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Streptococcus Pneumoniae Vaccine Sales Market Share, 2017-2028
Figure 19. US Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Streptococcus Pneumoniae Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Streptococcus Pneumoniae Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Streptococcus Pneumoniae Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Streptococcus Pneumoniae Vaccine Sales Market Share, 2017-2028
Figure 33. China Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Streptococcus Pneumoniae Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Streptococcus Pneumoniae Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Streptococcus Pneumoniae Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Streptococcus Pneumoniae Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Streptococcus Pneumoniae Vaccine by Region, 2021 VS 2028
Figure 50. Streptococcus Pneumoniae Vaccine Industry Value Chain
Figure 51. Marketing Channels


More Publications